Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 287

Detecting disease with a single molecule: Nanopore-based sensors could transform diagnostics

UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual molecules.

Since the molecules scientists want to detect—generally certain DNA or protein molecules—are roughly one-billionth of a meter wide, the they produce are very small and require specialized detection instruments.

“Right now, you need millions of molecules to detect diseases. We’re showing that it’s possible to get useful data from just a ,” said Kevin Freedman, assistant professor of bioengineering at UCR and lead author of a paper about the tool appearing in Nature Nanotechnology. “This level of sensitivity could make a real difference in disease diagnostics.”

Mitochondrial DNA plays an underappreciated role in leukemia development

Mitochondria are vital to energy production in cells and so play a key role in fueling cancer growth. However, how mitochondrial DNA (mtDNA) contributes to cancer has been unclear.

Scientists at St. Jude Children’s Research Hospital studied varying levels of mutated mtDNA to see their effect on . They found that while cancer growth was blocked in cells in which all mitochondria contained mutated mtDNA, it was notably increased in cells with moderate amounts of mutated mtDNA. By amplifying an enzyme vital to energy production, the researchers were also able to restart cancer growth in cells with fully mutated mtDNA.

Collectively, these findings highlight an unexplored connection between mitochondrial DNA and cancer cells’ metabolic function. The findings were published Jan. 1 in Science Advances.

New computational model can predict antibody structures more accurately

To overcome that limitation, MIT researchers have developed a computational technique that allows large language models to predict antibody structures more accurately. Their work could enable researchers to sift through millions of possible antibodies to identify those that could be used to treat SARS-CoV-2 and other infectious diseases.

The findings are published in the journal Proceedings of the National Academy of Sciences.

Chinese scientists find common blood pressure drug could cure rare brain tumour

Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain tumour.

Although craniopharyngioma is a benign tumour, it can cause complications due to its growth along the critical nerve structures of the brain close to the hypothalamus and the pituitary gland.

Given its location, the tumour can cause hormone dysfunction and metabolic disorders, like obesity, diabetes and hypothyroidism.

Fragile X Breakthrough: Study Shows Existing Drug Restores Early Communication

Research reveals distinct mechanisms underlying neonatal and post-pubertal social behaviors, providing valuable insights for developing targeted early interventions.

Researchers from the University of Texas Health Science Center at San Antonio and Hirosaki University have unveiled significant findings on the development of social behaviors in fragile X syndrome, the most common genetic cause of autism spectrum disorder. The study, published in Genomic Psychiatry, highlights the effects of a specific prenatal treatment on social behaviors in mice.

The researchers found that administering bumetanide—a drug that regulates chloride levels in neurons—to pregnant mice restored normal social communication in newborn pups with the fragile X mutation. However, they also discovered an unexpected outcome: the same treatment reduced social interaction after puberty in both fragile X and typical mice. These findings shed light on the complex and developmental-stage-specific effects of interventions for fragile X syndrome.

PROSPR: The Government Initiative To Extend Healthy Lifespan In America

“The ultimate goal is to extend healthspan—meaning the number of years aging adults live healthy lives and enjoy overall well-being by compressing the frailty and disability that comes with aging into a shorter duration of time near the end of life,” says Andrew Brack, PhD, the PROSPR Program Manager.

The new venture will be building on some of the work that the National Institute of Aging (NIH) has been working on and will be working in collaboration with various organizations in the biotechnology industry as well as some unspecified regulators to accelerate the development, testing, and availability of new therapeutic that targets human healthspan.

It is hoped that the new initiative, along with positively impacting the healthspan of Americans, will also help to enhance the economy across the nation.

New ‘all-optical’ nanoscale sensors of force access previously unreachable environments

Mechanical force is an essential feature for many physical and biological processes. Remote measurement of mechanical signals with high sensitivity and spatial resolution is needed for a wide range of applications, from robotics to cellular biophysics and medicine and even to space travel. Nanoscale luminescent force sensors excel at measuring piconewton forces, while larger sensors have proven powerful in probing micronewton forces.

However, large gaps remain in the force magnitudes that can be probed remotely from subsurface or interfacial sites, and no individual, non-invasive sensor has yet been able to make measurements over the large dynamic range needed to understand many systems.

“WWI Fighter Plane Hack” Inspires Breakthrough in Cancer Treatment

Researchers at the University of Massachusetts Amherst have developed an innovative technology inspired by the synchronization mechanism of WWI fighter aircraft, which coordinated machine gun fire with propeller movement. This breakthrough allows precise, real-time control of the pH in a cell’s environment to influence its behavior. Detailed in Nano Letters, the study opens exciting possibilities for developing new cancer and heart disease therapies and advancing the field of tissue engineering.

“Every cell is responsive to pH,” explains Jinglei Ping, associate professor of mechanical and industrial engineering at UMass Amherst and corresponding author of the study. “The behavior and functions of cells are impacted heavily by pH. Some cells lose viability when the pH has a certain level and for some cells, the pH can change their physiological properties.” Previous work has demonstrated that changes of pH as small as 0.1 pH units can have physiologically significant effects on cells.